Global prevalence of carbapenem- and colistin-resistant coliform isolates from wastewater: a systematic review and meta-analysis
4 affiliations
- 1HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences
- 2Department of Pathobiology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad
- 3Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences
- 4Department of Pathobiology, School of Veterinary Medicine, Shiraz University
Abstract
Carbapenems and colistin are considered last-resort antibiotics for treating infections caused by multidrug-resistant (MDR) bacteria. The emergence of carbapenem- and colistin-resistant coliforms in wastewater (WW) poses a serious environmental and public health threat. This systematic review and meta-analysis aimed to estimate the global pooled prevalence of carbapenem-resistant (CRR) and colistin-resistant (CLR) coliforms isolated from various types of WW. We systematically searched PubMed, Scopus, and Web of Science up to October 2024 to identify eligible observational studies. Data synthesis was conducted using random-effects meta-analysis. Subgroup analyses were performed by continent, WW type, bacterial species, and sample size. Publication bias was assessed using funnel plots, Begg’s and Egger’s tests, and the trim-and-fill method, while heterogeneity was evaluated using Cochran’s Q test and the I2 statistic. A total of 30 and 23 articles were included for CRR and CLR, respectively. Also, 4,990 and 3,589 coliform isolates were analyzed for CRR and CLR, respectively. The pooled prevalence of CRR coliforms was 35% (95% CI: 29–41; I2 = 98.9%), and CLR coliforms was 19% (95% CI: 14–23; I2 = 96.5%). The highest CRR prevalence was observed in Europe (43%; 95% CI: 22 – 63; I2 = 95.5%), and the highest CLR prevalence was reported in Asia (25%; 95% CI: 17 – 33; I2 = 95.3%). This study suggests that WW environments may serve as reservoirs for antibiotic-resistant coliforms. The observed prevalence of CRR and CLR coliforms in hospital and agricultural WW indicates a need for improved WW management, strengthened antimicrobial stewardship, and continued global surveillance within the One Health framework.
Related
- Outcomes of empirical ceftazidime avibactam plus colistin versus colistin regimens in carbapenem resistant gram negative infection under diagnostic uncertainty
- Cost-Effectiveness of Sulbactam-durlobactam Compared with Colistin for Treating Carbapenem-Resistant Acinetobacter baumannii Infections in Critical Care Settings in the United States
- Phenotypic and Genotypic Evaluation of Carbapenemases in Carbapenem-Resistant Klebsiella pneumoniae Isolates and Investigation of Ceftazidime-Avibactam and Colistin Susceptibility
- Wastewater is Not a Reliable Proxy for Clinical Carbapenem Resistance Prevalence in E. coli
- Prevalence, acquisition, and risk factors of carbapenem-resistant enterobacterales colonization in long-term care hospitals: A prospective active surveillance study
BibTeX
@article{zomorodi2026global,
title = {{Global prevalence of carbapenem- and colistin-resistant coliform isolates from wastewater: a systematic review and meta-analysis}},
author = {Abolfazl Rafati Zomorodi and Fatemeh Aflakian and Sepideh Askari and Mohammad Hassan Parvizi Mashhadi and Zahra Gholizadeh Farshi and Mohammad Motamedifar},
journal = {Scientific Reports},
year = {2026},
month = aug,
doi = {10.1038/s41598-026-65388-6},
url = {https://doi.org/10.1038/s41598-026-65388-6},
note = {CC BY},
}
RIS
TY - JOUR
TI - Global prevalence of carbapenem- and colistin-resistant coliform isolates from wastewater: a systematic review and meta-analysis
AU - Abolfazl Rafati Zomorodi
AU - Fatemeh Aflakian
AU - Sepideh Askari
AU - Mohammad Hassan Parvizi Mashhadi
AU - Zahra Gholizadeh Farshi
AU - Mohammad Motamedifar
PY - 2026
DA - 2026/08/01
JO - Scientific Reports
DO - 10.1038/s41598-026-65388-6
UR - https://doi.org/10.1038/s41598-026-65388-6
AB - Carbapenems and colistin are considered last-resort antibiotics for treating infections caused by multidrug-resistant (MDR) bacteria. The emergence of carbapenem- and colistin-resistant coliforms in wastewater (WW) poses a serious environmental and public health threat. This systematic review and meta-analysis aimed to estimate the global pooled prevalence of carbapenem-resistant (CRR) and colistin-resistant (CLR) coliforms isolated from various types of WW. We systematically searched PubMed, Scopus, and Web of Science up to October 2024 to identify eligible observational studies. Data synthesis was conducted using random-effects meta-analysis. Subgroup analyses were performed by continent, WW type, bacterial species, and sample size. Publication bias was assessed using funnel plots, Begg’s and Egger’s tests, and the trim-and-fill method, while heterogeneity was evaluated using Cochran’s Q test and the I2 statistic. A total of 30 and 23 articles were included for CRR and CLR, respectively. Also, 4,990 and 3,589 coliform isolates were analyzed for CRR and CLR, respectively. The pooled prevalence of CRR coliforms was 35% (95% CI: 29–41; I2 = 98.9%), and CLR coliforms was 19% (95% CI: 14–23; I2 = 96.5%). The highest CRR prevalence was observed in Europe (43%; 95% CI: 22 – 63; I2 = 95.5%), and the highest CLR prevalence was reported in Asia (25%; 95% CI: 17 – 33; I2 = 95.3%). This study suggests that WW environments may serve as reservoirs for antibiotic-resistant coliforms. The observed prevalence of CRR and CLR coliforms in hospital and agricultural WW indicates a need for improved WW management, strengthened antimicrobial stewardship, and continued global surveillance within the One Health framework.
SN - 2045-2322
ER -